• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases
      • All News Releases
      • All Public Company
      • English-only


      • News Releases Overview
      • Multimedia Gallery
      • All Multimedia
      • All Photos
      • All Videos


      • Multimedia Gallery Overview
      • Trending Topics
      • All Trending Topics


  • Business & Money
      • Auto & Transportation
      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation


      • Auto & Transportation Overview
      • Business Technology
      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors


      • Business Technology Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Financial Services & Investing
      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Stock Offering
      • Stock Split
      • Venture Capital


      • Financial Services & Investing Overview
      • General Business
      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News


      • General Business Overview
  • Science & Tech
      • Consumer Technology
      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications


      • Consumer Technology Overview
      • Energy & Natural Resources
      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities


      • Energy & Natural Resources Overview
      • Environ­ment
      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters


      • Environ­ment Overview
      • Heavy Industry & Manufacturing
      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco


      • Heavy Industry & Manufacturing Overview
      • Telecomm­unications
      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications


      • Telecomm­unications Overview
  • Lifestyle & Health
      • Consumer Products & Retail
      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys


      • Consumer Products & Retail Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Health
      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine


      • Health Overview
      • Sports
      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories


      • Sports Overview
      • Travel
      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry


      • Travel Overview
  • Policy & Public Interest
      • Policy & Public Interest
      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy


      • Policy & Public Interest Overview
  • People & Culture
      • People & Culture
      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women


      • People & Culture Overview
      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO

      Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Policy & Public Interest
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • People & Culture
    • People & Culture
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Psychemedics Corporation Announces Third Quarter Profits

EARNINGS UP 35% FROM Q3 2010


News provided by

Psychemedics Corporation

Nov 03, 2011, 01:08 ET

Share this article


ACTON, Mass., Nov. 3, 2011 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2011.  The Company also announced a quarterly dividend of $0.12 per share payable to shareholders of record as of November 17, 2011 to be paid on December 1, 2011.  This will be the Company's 61st consecutive quarterly dividend.

The Company's revenue for the quarter ended September 30, 2011 was $6.3 million versus $5.1 million for the quarter ended September 30, 2010, an increase of 24%.  Net income for the quarter ended September 30, 2011 was $1.1 million or $0.21 per diluted share, versus $817 thousand or $0.16 per diluted share, for the comparable period last year, an increase of 35%. The Company's revenue for the nine months ended September 30, 2011 was $18.5 million, as compared to $15.0 million for the comparable period of 2010, an increase of 24%. Net income for the nine months ended September 30, 2011 was $3.1 million or $0.58 per diluted share, as compared to last year during which the Company earned $2.2 million or $0.42 per diluted share, an increase of 39%.

Raymond C. Kubacki, Chairman and Chief Executive Officer, said,

"Our third quarter results were strong, both on the top line as well as earnings.  The majority of our growth came from new business. However, in light of the current tepid economic environment, we were also encouraged to see growth in our base business.  We continued to have robust margins including a 29% pre-tax margin. While we maintained tight cost control, we also continue to make investments in sales and marketing. 

"Our balance sheet remained strong with no long-term debt and cash of $3.5 million.  There was a temporary increase in accounts receivable and corresponding reduction of cash from prior quarters due to a delay in August invoicing as a result of a one-time upgrade to our billing system. 

"Our directors share our confidence in the long-term future of Psychemedics and remain committed to rewarding shareholders and sharing the financial success of the Company with them as we move forward.     

"Therefore, the Board has declared a $0.12 dividend for the quarter. This is our 61st consecutive quarterly dividend. In addition, we continue to have a share buyback program in place."

Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the patented Psychemedics drug testing services.  Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and six Federal Reserve Banks.

The Psychemedics web site is www.psychemedics.com

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995:  From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties.  In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning earnings, earnings per share, revenues, dividends, future business, growth opportunities, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements.  Actual results may differ from those stated in any forward-looking statements.  Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing team, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.

Contact: Neil Lerner

Vice President of Finance

(978) 206-8220

[email protected]  

 

PSYCHEMEDICS CORPORATION
STATEMENTS OF INCOME
(UNAUDITED)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2011

 

2010

 

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$6,315,142

 

$5,106,262

 

 

$18,542,666

 

$14,992,625

 

 

Cost of revenues

2,371,255

 

2,080,214

 

 

7,243,474

 

6,033,093

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

3,943,887

 

3,026,048

 

 

11,299,192

 

8,959,532

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

   General & administrative

1,018,967

 

850,312

 

 

2,898,426

 

2,760,195

 

 

   Marketing & selling

981,197

 

722,815

 

 

2,945,492

 

2,098,192

 

 

   Research & development

136,281

 

116,534

 

 

399,785

 

364,445

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

2,136,445

 

1,689,661

 

 

6,243,703

 

5,222,832

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

1,807,442

 

1,336,387

 

 

5,055,489

 

3,736,700

 

 

Interest income

773

 

4,940

 

 

4,790

 

19,422

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income before provision for income taxes

1,808,215

 

1,341,327

 

 

5,060,279

 

3,756,122

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

708,830

 

523,959

 

 

2,009,184

 

1,559,391

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$1,099,385

 

$817,368

 

 

$3,051,095

 

$2,196,731

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per share

$0.21

 

$0.16

 

 

$0.58

 

$0.42

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per share

$0.21

 

$0.16

 

 

$0.58

 

$0.42

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per share

$0.12

 

$0.12

 

 

$0.36

 

$0.36

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic

5,237,603

 

5,212,835

 

 

5,227,699

 

5,205,480

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, diluted

5,240,895

 

5,228,378

 

 

5,234,577

 

5,219,760

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

PSYCHEMEDICS CORPORATION
BALANCE SHEETS
(UNAUDITED)

 

 

 

 

September 30,

 

December 31,

 

 

 

2011

 

2010

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 Current Assets:

 

 

 

 

 

   Cash and cash equivalents

$3,501,525

 

$3,720,488

 

 

   Short-term investments

--

 

2,018,452

 

 

   Accounts receivable, net of allowance for doubtful accounts

6,197,433

 

3,905,821

 

 

       of $138,067 in 2011 and $119,295 in 2010

 

 

 

 

 

   Prepaid expenses and other current assets

836,069

 

700,822

 

 

   Deferred tax assets  

362,153

 

239,831

 

 

 

 

 

 

 

 

Total Current Assets

10,897,180

 

10,585,414

 

 

 

 

 

 

 

 

Fixed Assets:

 

 

 

 

 

   Equipment & leasehold improvements

12,643,486

 

11,730,866

 

 

   Less accumulated depreciation

(10,917,452)

 

(10,663,996)

 

 

 

 

 

 

 

 

Net Fixed Assets

1,726,034

 

1,066,870

 

 

 

 

 

 

 

 

Other Assets

222,724

 

114,037

 

 

 

 

 

 

 

 

Total Assets

$  12,845,938

 

$ 11,766,321

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

   Accounts payable

$293,930

 

$699,833

 

 

   Accrued expenses

1,440,986

 

1,302,370

 

 

   Deferred revenue

--

 

16,605

 

 

 

 

 

 

 

 

Total Current Liabilities

1,734,916

 

2,018,808

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity:

 

 

 

 

 

   Preferred-stock, $0.005 par value, 872,521 shares authorized,

 

 

 

 

 

        no shares issued or outstanding

--

 

--

 

 

   Common stock, $0.005 par value; 50,000,000 shares authorized

 

 

 

 

 

       5,903,552 shares issued in 2011 and 5,877,358 shares issued 2010 

29,518

 

29,387

 

 

   Paid-in capital

27,982,277

 

27,764,992

 

 

   Accumulated deficit

(6,818,984)

 

(7,987,468)

 

 

   Less - Treasury stock at cost, 668,130 shares in 2011 and 665,345 in 2010

(10,081,789)

 

(10,059,398)

 

 

 

 

 

 

 

 

Total Shareholders' Equity

11,111,022

 

9,747,513

 

 

 

 

 

 

 

 

Total Liabilities and Shareholders' Equity

$12,845,938

 

$11,766,321

 

 

 

 

 

 

 

 

SOURCE Psychemedics Corporation

Modal title

    Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

    Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

    About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement

    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom

    My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision


Products


About


My Services
  • All News Releases
  • Online Member Center
  • ProfNet℠
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2021 Cision US Inc.